AAUM (Average Assets Under Management) of ₹2,205.36 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Banks | 18.5% | 18.3% | ▼ -0.2% |
| Pharmaceuticals & Biotechnology | 8.2% | 8.3% | ● +0.1% |
| Retailing | 4.9% | 5.8% | ▲ +0.9% |
| Finance | 5.1% | 5.0% | ▼ -0.1% |
| Automobiles | 4.8% | 4.8% | ● +0.0% |
| Telecom - Services | 4.2% | 4.3% | ● +0.0% |
| Food Products | 3.4% | 3.4% | ● +0.0% |
| IT - Software | 3.3% | 3.4% | ● +0.1% |
| Consumer Durables | 3.1% | 3.2% | ▲ +0.1% |
| Capital Markets | 2.8% | 3.0% | ▲ +0.2% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Banks | 18.3% | 18.1% | ▼ -0.3% |
| Pharmaceuticals & Biotechnology | 8.3% | 9.1% | ▲ +0.8% |
| Retailing | 5.8% | 5.7% | ● 0.0% |
| Finance | 5.0% | 4.8% | ▼ -0.2% |
| Telecom - Services | 4.3% | 4.3% | ● +0.1% |
| Automobiles | 4.8% | 4.2% | ▼ -0.7% |
| Capital Markets | 3.0% | 3.6% | ▲ +0.6% |
| Food Products | 3.4% | 3.4% | ● -0.1% |
| IT - Software | 3.4% | 3.1% | ▼ -0.3% |
| Consumer Durables | 3.2% | 3.0% | ▼ -0.2% |
Comparing Aug 2026 → Sep 2026
| # | Stock | Sector | Weight (Sep 2026) |
|---|---|---|---|
| 1 | National Stock Exchange of India Ltd. ₹12.34 Cr |
Capital Markets | 0.52% |
| 2 | Meesho Ltd ₹8.55 Cr |
Retailing | 0.36% |
| 3 | Bosch Limited ₹6.17 Cr |
Auto Components | 0.26% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Divi's Laboratories Limited ₹26.52 Cr |
Pharmaceuticals & Biotechnology | 0.30% | 1.12% | +0.82% |
| 2 | Tech Mahindra Limited ₹18.20 Cr |
IT - Software | 0.01% | 0.77% | +0.76% |
| 3 | KEI Industries Limited ₹19.88 Cr |
Industrial Products | 0.08% | 0.84% | +0.76% |
| 4 | Infosys Limited ₹10.81 Cr |
IT - Software | 0.00% | 0.46% | +0.46% |
| 5 | Eternal Limited ₹57.26 Cr |
Retailing | 2.16% | 2.41% | +0.25% |
| 6 | Mankind Pharma Limited ₹9.90 Cr |
Pharmaceuticals & Biotechnology | 0.20% | 0.42% | +0.22% |
| 7 | HDFC Bank Limited ₹64.61 Cr |
Banks | 2.56% | 2.72% | +0.16% |
| 8 | Laurus Labs Limited ₹41.48 Cr |
Pharmaceuticals & Biotechnology | 1.59% | 1.75% | +0.16% |
| 9 | The Phoenix Mills Limited ₹36.89 Cr |
Realty | 1.44% | 1.55% | +0.11% |
| 10 | Motilal Oswal Financial Services Limited ₹26.05 Cr |
Capital Markets | 1.00% | 1.10% | +0.10% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | PB Fintech Limited ₹2.88 Cr |
Financial Technology (Fintech) | 1.90% | 0.12% | -1.78% |
| 2 | Sona BLW Precision Forgings Limited ₹45.04 L |
Auto Components | 0.96% | 0.02% | -0.94% |
| 3 | Persistent Systems Limited ₹16.60 Cr |
IT - Software | 1.62% | 0.70% | -0.92% |
| 4 | Vishal Mega Mart Limited ₹12.72 Cr |
Retailing | 1.22% | 0.54% | -0.68% |
| 5 | Ather Energy Limited ₹9.41 L |
Automobiles | 0.51% | 0.00% | -0.51% |
| 6 | Oracle Financial Services Software Limited ₹67.39 L |
IT - Software | 0.53% | 0.03% | -0.50% |
| 7 | Max Financial Services Limited ₹42.31 Cr |
Insurance | 2.14% | 1.78% | -0.36% |
| 8 | Torrent Pharmaceuticals Limited ₹26.06 Cr |
Pharmaceuticals & Biotechnology | 1.44% | 1.10% | -0.34% |
| 9 | Sun Pharmaceutical Industries Limited ₹10.51 Cr |
Pharmaceuticals & Biotechnology | 0.71% | 0.44% | -0.27% |
| 10 | ICICI Bank Limited ₹157.58 Cr |
Banks | 6.87% | 6.63% | -0.24% |
113 stocks — Sep 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹157.58 Cr |
Banks |
6.63%
|
|
| 2 |
₹80.28 Cr |
Food Products |
3.38%
|
|
| 3 |
₹64.99 Cr |
Telecom - Services |
2.73%
|
|
| 4 |
₹64.61 Cr |
Banks |
2.72%
|
|
| 5 |
₹57.26 Cr |
Retailing |
2.41%
|
|
| 6 |
₹52.85 Cr |
Banks |
2.22%
|
|
| 7 |
₹50.54 Cr |
Automobiles |
2.13%
|
|
| 8 |
₹46.83 Cr |
Banks |
1.97%
|
|
| 9 |
₹42.31 Cr |
Insurance |
1.78%
|
|
| 10 |
₹41.48 Cr |
Pharmaceuticals & Biotechnology |
1.75%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.